Aberdeen Pain Research Collaboration (Epidemiology Group), School of Medicine and Dentistry, University of Aberdeen, Foresterhill, Aberdeen AB25 2ZD, Scotland, UK.
Rheumatology (Oxford). 2010 Jun;49(6):1063-8. doi: 10.1093/rheumatology/keq025. Epub 2010 Mar 3.
To critically evaluate the evidence regarding complementary and alternative medicines (CAMs) taken orally or applied topically for the treatment of FM.
Randomized controlled trials of FM using CAMs, in comparison with other treatments or placebo, published in English up to March 2009, were eligible for inclusion. They were identified using systematic searches of bibliographic databases and manual searching of reference lists. Information was extracted on outcomes, and statistical significance, in comparison with alternative treatment or placebo, and side effects were reported. The methodological quality of the primary studies was determined.
Single studies on four CAMs, and three on different approaches to homeopathic care were identified. Their methodological quality was moderate. The homeopathy studies were small, but each reported an improvement in pain. The effects of anthocyanidins, capsaicin and S-adenosylmethionine each showed at least one statistically significant improved outcome compared with placebo. However, the studies of anthocyanidins and capsaicin only demonstrated an improvement in a single outcome, sleep disturbance and tenderness, respectively, of several outcomes considered. No evidence of efficacy was found regarding Soy in a single study. Most of these CAMs were free of major adverse effects and usually associated with only minor adverse effects such as dizziness, nausea and stomach upsets.
There is insufficient evidence on any CAM, taken orally or applied topically, for FM. The small number of positive studies lack replication. Further high-quality trials are necessary to determine whether these initial findings can be supported by a larger evidence base.
系统评价口服或局部应用补充替代医学(CAM)治疗纤维肌痛(FM)的证据。
检索截止 2009 年 3 月公开发表的、用 CAM 治疗 FM 的随机对照试验,与其他治疗或安慰剂对照,符合纳入标准的研究进行资料提取和质量评价。
共纳入 4 项 CAM 单一药物研究和 3 项顺势疗法研究,CAM 单一药物研究的方法学质量为中等,顺势疗法研究的样本量较小,但均报道疼痛缓解。与安慰剂相比,花色苷、辣椒素和 S-腺苷蛋氨酸均有至少一项结局指标的改善有统计学意义,但花色苷和辣椒素仅在部分结局指标中有改善,花色苷改善睡眠障碍,辣椒素改善压痛。1 项大豆研究未发现疗效。这些 CAM 药物通常无严重不良反应,仅有轻微不良反应,如头晕、恶心和胃部不适。
目前尚无任何一种 CAM 药物(口服或局部应用)治疗 FM 的高质量证据,阳性研究数量较少且缺乏重复性,需要进一步开展高质量临床试验来验证这些初步研究结果。